Condition: Advanced Ovarian Carcinoma · Fallopian Tube Clear Cell Adenocarcinoma · Fallopian Tube Endometrioid Tumor · Sponsor: M.D. Anderson Cancer Center
This phase III trial compares minimally invasive surgery (MIS) to laparotomy in treating patients with stage IIIC-IV ovarian, primary peritoneal, or fallopian tube cancer who are receiving chemotherapy before and after surgery (neoadjuvant chemotherapy). MIS is a surgical procedure that uses small incision(s) and is intended to produce minimal blood loss and pain for the patient. Laparotomy is a surgical procedure which allows the doctors to remove some or all of the tumor and check if the disease has spread to other organs in the body. MIS may work the same or better than standard laparotomy after chemotherapy in prolonging the return of the disease and/or improving quality of life after surgery.
This description comes directly from the study's public registry record.
Jose A. Rauh-Hain, MD, MPH · 713-794-1759 · jarauh@mdanderson.org
Always discuss trial participation with your own doctor first.
| University of Miami Miller School of Medicine-Sylvester Cancer Center | Miami, Florida, United States | Recruiting |
| Cleveland Clinic Foundation - Florida | Weston, Florida, United States | Recruiting |
| Massachusetts General Hospital | Boston, Massachusetts, United States | Recruiting |
| Dana Farber Cancer Institute | Boston, Massachusetts, United States | Recruiting |
| NYU Langone Health | Mineola, New York, United States | Recruiting |
| Columbia University Medical Center | New York, New York, United States | Recruiting |
| Duke | Durham, North Carolina, United States | Recruiting |
| Cleveland Clinic | Cleveland, Ohio, United States | Recruiting |
| St. Luke's University Health Network | Bethlehem, Pennsylvania, United States | Recruiting |
| Lyndon Baines Johnson General | Houston, Texas, United States | Recruiting |
| Houston Methodist | Houston, Texas, United States | Recruiting |
| M D Anderson Cancer Center | Houston, Texas, United States | Recruiting |
+ 7 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04575935